Specialty pharmaceutical company

Providing solutions to unmet medical needs.

Shield Therapeutics is a specialty pharmaceutical company focused on the development and commercialisation of late‑stage, hospital‑focused pharmaceuticals which address areas of unmet medical need.

Find out more

Shield Therapeutics CEO hails positive head-to-head Feraccru study results

Mar 2019 - 5:28
View all Investors Audio & Video

Our Products

A treatment for iron deficiency anaemia

Our lead product, Feraccru®, is a novel oral ferric iron therapy that is approved and marketed in the European Union for the treatment of Iron Deficiency (ID) with or without anaemia in adults and in Switzerland for the treatment of Iron Deficiency Anaemia (IDA) in adults with inflammatory bowel disease (IBD).

Find out more